Molecular Diagnosis Firm BillionToOne Raises $273 Million in IPO
BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.
By Amethyst Martinez · Bloomberg
BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.